The WACC of Prelude Therapeutics Inc (PRLD) is 8.8%.
Range | Selected | |
Cost of equity | 12.20% - 15.60% | 13.90% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 7.9% - 9.6% | 8.8% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 1.81 | 1.91 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 12.20% | 15.60% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 7.9% | 9.6% |
Selected WACC | 8.8% | |